Cognetivity Looks To Raise $3.0 Million To Fund US Expansion

Cognetivity Neurosciences (CSE: CGN) is looking to close out the year with a capital raise. The firm last night indicated it intends to conduct a non-brokered private placement for gross proceeds of $3.0 million.

The financing will see the company sell roughly 5.5 million units, with each unit being priced at $0.55 per each. Each unit is set to contain one common share and one half of a purchase warrant, with each warrant valid for a period of three years and containing an exercise price of $0.85 per share.

Proceeds from the offering are to be used to expand the firms operations in the US, customer and technical support, marketing, and general operations.

The financing is currently slated to close by January 31, 2022.

Cognetivity Neuroscience last traded at $0.56 on the CSE.


FULL DISCLOSURE: Cognetivity Neurosciences Ltd is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover Cognetivity Neurosciences Ltd on The Deep Dive, with The Deep Dive having full editorial control. We may buy or sell securities in the company at any time. Not a recommendation to buy or sell. We may buy or sell securities in the company at any time. Always do additional research and consult a professional before purchasing a security.

Video Articles

First Majestic Q3 Earnings: Another RECORD Quarter!

Barrick Q3 Earnings: Juicing Shareholder Returns Amid Declining Production

Wheaton Q3 Earnings: Cash Operating Margins Skyrocket

Recommended

Goliath Resources Extends High Grade Zone To 580 Metres In Latest Assays

Emerita Resources Hits 2.7% Copper, 1.85 g/t Gold Over 9.6 Metres At El Cura

Related News

Cognetivity Enters Distribution Arrangement For Dementia Product In Middle East

Cognetivity Neurosciences (CSE: CGN) is expanding its global distribution. The firm this morning announced it...

Thursday, January 27, 2022, 09:09:29 AM

Cognetivity Neurosciences Selected For Accelerator Program To Fast Track US Commercialization

Cognetivity Neurosciences (CSE: CGN) has been selected as one of just seven members of the...

Wednesday, December 23, 2020, 09:08:31 AM

Cognetivity: Echelon Raises Price Target To $1.50 After Biogen Approval

Monday was a very big day for companies who are in the business to help...

Wednesday, June 9, 2021, 11:22:00 AM

Cognetivity Sees Its Cognitive Tool Used In Clinical Study For OCD

While it may have been initially developed for the early detection of Alzheimer’s disease or...

Tuesday, September 13, 2022, 08:38:28 AM

Cognetivity Sees Pilot Program Transition Into Commercial Agreement In UAE

A successful pilot program has lead to a commercial arrangement for Cognetivity Neurosciences (CSE: CGN)....

Wednesday, June 15, 2022, 07:23:20 AM